Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Macrogenics Mgnx Stock Crashes After Reporting Patient Deaths In Tamarack Study – Hagens Berman is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
MacroGenics (MGNX) Investigating Three of Five Patient Deaths in ...
The current investigation scrutinizes the accuracy of MacroGenics’ statements regarding data from its Phase 2 TAMARACK study of the antibody-drug conjugate MGC018, known as “vobra duo,” in ... Read More
MacroGenics (MGNX) Crashed 28% After Pausing Phase 2 TAMARACK Study ...
On July 30, 2024, shares in beleaguered pharmaceutical company MacroGenics crashed after the company provided an update for the Phase 2 TAMARACK study on its experimental cancer drug, vobra duo. Read More
After Reporting Five Patient Deaths, Data Committee Recommends ...
MacroGenics will discontinue vobra duo for remaining mCRPC participants after five deaths. New data to be presented at ESMO 2024 conference. Read More
MacroGenics (MGNX) Faces Class Action After Revealing ... - FOX40
Class Action Lawsuit Against MacroGenics, Inc. (MGNX): The litigation focuses on the accuracy of MacroGenics' statements regarding data from its Phase 2 TAMARACK study of the antibody-drug ... Read More
MacroGenics (MGNX) Faces Class Action After Revealing ... - PIX11
Class Action Lawsuit Against MacroGenics, Inc. (MGNX): The litigation focuses on the accuracy of MacroGenics’ statements regarding data from its Phase 2 TAMARACK study of the antibody-drug ... Read More
MacroGenics (MGNX) Faces Class Action After Revealing Investigation of ...
The litigation focuses on the accuracy of MacroGenics' statements regarding data from its Phase 2 TAMARACK study of the antibody-drug conjugate MGC018, known as "vobra duo," in patients with ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus